Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
3.770
-0.190 (-4.80%)
At close: Jan 15, 2026, 4:00 PM EST
3.790
+0.020 (0.53%)
After-hours: Jan 15, 2026, 6:59 PM EST

Climb Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
1801217498278-
Upgrade
Market Cap Growth
44.73%62.54%-23.65%-64.90%--
Upgrade
Enterprise Value
5-97-33-32108-
Upgrade
Last Close Price
3.771.802.703.6710.46-
Upgrade
PB Ratio
1.450.570.690.761.66-
Upgrade
P/TBV Ratio
1.020.570.690.761.66-
Upgrade
Debt / Equity Ratio
0.000.000.000.00--
Upgrade
Quick Ratio
17.5630.8338.5721.3523.798.16
Upgrade
Current Ratio
18.3831.4138.9222.0424.588.76
Upgrade
Return on Equity (ROE)
-25.65%-46.26%-29.72%-30.58%-50.16%-96.73%
Upgrade
Return on Assets (ROA)
-17.35%-10.30%-10.93%-18.30%-22.54%-31.96%
Upgrade
Return on Capital (ROIC)
-17.70%-10.54%-11.31%-19.04%-23.55%-34.42%
Upgrade
Return on Capital Employed (ROCE)
-31.70%-12.70%-19.90%-35.00%-21.30%-53.20%
Upgrade
Earnings Yield
-28.20%-61.07%-47.17%-46.40%-17.09%-
Upgrade
Buyback Yield / Dilution
-76.96%-78.47%-2.57%-114.60%-460.40%-31.72%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q